Brand family
Creon
United States
- Presentations
- 5
- Markets
- 1
Creon is a brand of Pancrelipase amylase, Pancrelipase lipase and Pancrelipase protease marketed by AbbVie, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Pancrelipase amylase, Pancrelipase lipase and Pancrelipase protease
- Brand owner
- AbbVie
- Registered in
- United States
- Strengths and forms
- 120000 units/24000 units/76000 units delayed-release capsule, 15000 units/3000 units/9500 units delayed-release capsule, 180000 units/36000 units/114000 units delayed-release capsule, 30000 units/6000 units/19000 units delayed-release capsule, 60000 units/12000 units/38000 units delayed-release capsule
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Creon 120000 units/24000 units/76000 units delayed-release capsuleOral | AbbVie | US FDA | Available on request |
| Creon 15000 units/3000 units/9500 units delayed-release capsuleOral | AbbVie | US FDA | Available on request |
| Creon 180000 units/36000 units/114000 units delayed-release capsuleOral | AbbVie | US FDA | Available on request |
| Creon 30000 units/6000 units/19000 units delayed-release capsuleOral | AbbVie | US FDA | Available on request |
| Creon 60000 units/12000 units/38000 units delayed-release capsuleOral | AbbVie | US FDA | Available on request |
Equivalent brands
Other brands of Pancrelipase amylase, Pancrelipase lipase and Pancrelipase protease.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Creon
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.